These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 17398305)

  • 21. [Integrated treatment of the symptoms of narcolepsy-cataplexy syndrome with sodium oxybate].
    Poza-Aldea JJ
    Rev Neurol; 2009 Jan 1-15; 48(1):27-31. PubMed ID: 19145563
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Olfactory dysfunction in patients with narcolepsy with cataplexy is restored by intranasal Orexin A (Hypocretin-1).
    Baier PC; Weinhold SL; Huth V; Gottwald B; Ferstl R; Hinze-Selch D
    Brain; 2008 Oct; 131(Pt 10):2734-41. PubMed ID: 18718966
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cataplexy treated with escitalopram--clinical experience.
    Sonka K; Kemlink D; Pretl M
    Neuro Endocrinol Lett; 2006; 27(1-2):174-6. PubMed ID: 16648807
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Venlafaxine plus mirtazapine as first-line treatment for melancholia: preliminary results.
    Ruiz-Doblado S; Rueda-Villar T; Zurita-Gotor P; Sanz-Cortes S
    J Psychopharmacol; 2010 Dec; 24(12):1837. PubMed ID: 21138931
    [No Abstract]   [Full Text] [Related]  

  • 25. Augmentation of venlafaxine with bupropion: risks associated with a triple monoamine reuptake inhibition approach to partially responsive depression.
    Andrade C
    J Clin Psychiatry; 2013 Feb; 74(2):e119-21. PubMed ID: 23473356
    [No Abstract]   [Full Text] [Related]  

  • 26. A note on cataplexy treated with protriptyline.
    Gross MD
    Dis Nerv Syst; 1969 Jun; 30(6):418. PubMed ID: 5809297
    [No Abstract]   [Full Text] [Related]  

  • 27. Sodium oxybate for cataplexy.
    Lemon MD; Strain JD; Farver DK
    Ann Pharmacother; 2006 Mar; 40(3):433-40; quiz 581-2. PubMed ID: 16507620
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Narcolepsy: treatment issues.
    Roth T
    J Clin Psychiatry; 2007; 68 Suppl 13():16-9. PubMed ID: 18078361
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Optimal dosing of desvenlafaxine, new insights in gambling and anorexia, and caffeine-induced psychosis.
    Hollander E
    CNS Spectr; 2009 Mar; 14(3):116-7. PubMed ID: 19407706
    [No Abstract]   [Full Text] [Related]  

  • 30. The effect of intranasal orexin-A (hypocretin-1) on sleep, wakefulness and attention in narcolepsy with cataplexy.
    Weinhold SL; Seeck-Hirschner M; Nowak A; Hallschmid M; Göder R; Baier PC
    Behav Brain Res; 2014 Apr; 262():8-13. PubMed ID: 24406723
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An update on the pharmacotherapy of excessive daytime sleepiness and cataplexy.
    Mignot E
    Sleep Med Rev; 2004 Oct; 8(5):333-8. PubMed ID: 15336234
    [No Abstract]   [Full Text] [Related]  

  • 32. Mania after venlafaxine withdrawal in a patient with generalized anxiety disorder.
    Khazaal Y
    Ann Pharmacother; 2007 Feb; 41(2):359-60. PubMed ID: 17284507
    [No Abstract]   [Full Text] [Related]  

  • 33. Xyrem approved for muscle problems in narcolepsy.
    FDA Consum; 2002; 36(5):7. PubMed ID: 12412541
    [No Abstract]   [Full Text] [Related]  

  • 34. Sodium oxybate for excessive daytime sleepiness in narcolepsy-cataplexy.
    Arnulf I; Mignot E
    Sleep; 2004 Nov; 27(7):1242-3. PubMed ID: 15586777
    [No Abstract]   [Full Text] [Related]  

  • 35. Sodium oxybate in narcolepsy with cataplexy: Zurich sleep center experience.
    Poryazova R; Tartarotti S; Khatami R; Baumann CR; Valko P; Kallweit U; Werth E; Bassetti CL
    Eur Neurol; 2011; 65(3):175-82. PubMed ID: 21389728
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A study on cataplexy.
    Guilleminault C; Wilson RA; Dement WC
    Arch Neurol; 1974 Oct; 31(4):255-61. PubMed ID: 4369737
    [No Abstract]   [Full Text] [Related]  

  • 37. Neurologic, psychiatric and biochemical aspects of Gélineau's syndrome.
    Parkes JD; Roy A
    Trans Am Neurol Assoc; 1974; 99():103-6. PubMed ID: 4463519
    [No Abstract]   [Full Text] [Related]  

  • 38. Psychological factors affecting response to antidepressant drugs in fibromyalgia.
    Díaz-Marsá M; Palomares N; Morón MD; Tajima K; Fuentes ME; López-Ibor JJ; Carrasco JL
    Psychosomatics; 2011; 52(3):237-44. PubMed ID: 21565595
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Effect of the new drug provisions on the drug treatment of narcolepsy].
    Mayer G
    Dtsch Med Wochenschr; 2004 May; 129(21):1198-201. PubMed ID: 15160324
    [No Abstract]   [Full Text] [Related]  

  • 40. Sulpiride, a D2/D3 blocker, reduces cataplexy but not REM sleep in canine narcolepsy.
    Okura M; Riehl J; Mignot E; Nishino S
    Neuropsychopharmacology; 2000 Nov; 23(5):528-38. PubMed ID: 11027918
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.